William Rosellini

"I envision a future where advances in computer intelligence and human health combine"

Will Rosellini is the CEO of Perimeter Medical, Inc and the Chairman of Nexeon Medsystems, Inc., a medical device manufacturing company that went public in 2017. He is a former pitcher with the Arizona Diamondbacks, holds a JD, MBA, MS of Accounting, MS of Computational Biology, MS of Neuroscience, and MS of Regulatory Science.


Perimeter Medical Imaging

Perimeter Medical develops, patents, and commercializes advanced in-procedural medical imaging tools.

The OTIS™ platform provides clinicians with real-time, ultra-high resolution, sub-surface image volumes of the margin (1-2 mm below the surface) of an excised tissue specimen. The ability to visualize microscopic tissue structures during the clinical procedure has the potential to result in better long-term outcomes for patients and lower costs to the healthcare system.


https://www.perimetermed.com

Nexeon Medsystems

A global medical device company focused on providing innovative neurostimulation products

Nexeon improves the quality of life of patients suffering from debilitating neurological disease.


https://www.nexeonmed.com

MicroTransponder

MicroTransponder Inc. (MTI) has developed the Paired Vagus Nerve Stimulation System (Paired VNS™ System) based on decades of neuroscience research. The Paired VNS™ System has been developed to treat two separate neurological conditions. The first is the Serenity® System for the treatment of chronic tinnitus. The second is the Vivistim® System for treatment of post-stroke upper limb mobility issues.


http://www.microtransponder.com